Licoflavone cyclodextrin poloxamer ternary supramolecular inclusion compound as well as preparation method and application thereof
Through the ternary supramolecular inclusion technology of licorice flavonoids, cyclodextrin and poloxamer, the problem of insufficient solubility of licorice flavonoids in gastric juice is solved, and its bioavailability and efficacy are significantly improved, especially in the repair of gastric ulcers. It showed significant results.
Patent Information
- Application Number
- CN202411143166.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-20
- Publication Date
- 2024-11-26
AI Technical Summary
The existing licorice flavonoids have low solubility and bioavailability, especially in gastric juice, which leads to limited improvement in drug efficacy.
The ternary supramolecular inclusion complexes are prepared by mixing ethanol and water and spray-drying processes to form a ternary supramolecular inclusion complex with an outer hydrophilic and inner hydrophobic cavity structure. Improve the solubility and bioavailability of licorice flavonoids.
The solubility and stability of licorice flavonoids in aqueous solution were significantly improved, the bioavailability increased by 172.8%, and showed a significant repair effect in the gastric ulcer model, improving the efficacy of the medicine.
Smart Images

Figure CN119015441A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of biomedicine, and in particular to a ternary supramolecular inclusion compound of glycyrrhizin flavonoids, cyclodextrin and poloxamer, and a preparation method and application thereof. Background Art
[0002] Licorice is one of the most commonly used Chinese medicinal materials in my country. It was first recorded in Shennong's Herbal Classic and is known as "Nine Herbs in Ten Formulas". It has the effects of tonifying the spleen and replenishing qi, clearing away heat and detoxifying, removing phlegm and relieving cough, and harmonizing various medicines. Licorice flavonoids are an important biologically active substance extracted from licorice, mainly including liquiritigenin, isoliquiritigenin, liquiritigenin, isoliquiritigenin, chalcone A, etc. Existing technologies show that licorice flavonoids have anti-cancer effects, can inhibit the growth of gastric cancer transplanted tumors in nude mice, and can down-regulate the expression of proliferating cell nuclear antigen (PCNA) in gastric cancer tissues; can significantly inhibit the replication and synthesis of DNA and RNA in tumor cells of S180 and H22 tumor-bearing mice; have anti-inflammatory and anti-gastric ulcer and duodenal ulcer effects, can inhibit the expression of proinflammatory cytokines, cyclooxygenase-2 and ICAM-1, and reduce the translocation of nuclear transcription factor kappa-B subunit p65 protein to the cell nucleus, thereby showing strong anti-inflammatory activity; licorice flavonoids play an anti-ulcer role in the ulcerative colitis mouse model induced by dextran sodium sulfate by reducing oxidative stress and proinflammatory cytokines, regulating the nuclear transcription factor erythroid two-related factor (Nrf2) pathway and the nuclear transcription factor expression down-regulation kappa-B pathway.
[0003] Although licorice flavonoids have multiple pharmacological activities, their bioavailability is low due to their poor solubility, low bioavailability, large daily dosage and frequent administration after preparation. In response to the above situation, a variety of methods have been developed in recent years to improve the bioavailability of oral administration, such as microcapsules, liposomes, inclusion, microemulsion, self-emulsification, etc. The inclusion method has the advantages of increasing drug solubility and improving drug stability, but in the prior art, glycyrrhizin is mainly included by cyclodextrin, such as CN201110223709.4 discloses a hydroxypropyl-β-cyclodextrin complex inclusion compound of glycyrrhizin and ferulic acid and a preparation method; CN201110002457.2 discloses a method for preparing water-soluble glycyrrhizin by including glycyrrhizin with β-cyclodextrin; "Study on the Preparation and Solubilization of Glycyrrhizin-HP-β-CD Inclusion Compound" discloses a method for preparing glycyrrhizin-HP-β-CD inclusion compound by saturated aqueous solution method; "Study on the Preparation and Solubilization of Glycyrrhizin-β-CD Inclusion Compound" discloses a method for preparing glycyrrhizin-β-CD inclusion compound by saturated aqueous solution method; "Optimization of Glycyrrhizin-β-cyclodextrin Inclusion Process" discloses methods for preparing glycyrrhizin-β-cyclodextrin inclusion compound by saturated aqueous solution method, ultrasonic method and grinding method respectively. The inclusion compounds prepared by cyclodextrin inclusion of glycyrrhizin are basically binary inclusion compounds. Although the solubility of glycyrrhizin is improved, its final solubility is still low, especially the solubility in gastric juice is low, the formed drug concentration is limited, and the improvement of drug efficacy is small. Therefore, it is necessary to provide a new glycyrrhizin inclusion compound to improve the solubility, bioavailability, solubility and dissolution of glycyrrhizin in gastric juice. Summary of the invention
[0004] The purpose of the present invention is to provide a ternary supramolecular inclusion compound of glycyrrhizin cyclodextrin poloxamer and a preparation method and application thereof, so as to improve the solubility, bioavailability, solubility and dissolution rate of glycyrrhizin in the inclusion compound in gastric juice.
[0005] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:
[0006] The invention provides a ternary supramolecular inclusion compound of glycyrrhizin cyclodextrin and poloxamer, which is prepared from the following components in parts by weight: 0.8 to 1.2 parts of glycyrrhizin cyclodextrin, 1 to 10 parts of cyclodextrin and 1 to 3 parts of poloxamer.
[0007] Preferably, the glycyrrhiza flavonoids is a glycyrrhiza flavonoids extract extracted from the residue after water extraction of licorice, and the content of flavonoids in the glycyrrhiza flavonoids is ≥80.0%.
[0008] Preferably, the cyclodextrin is hydroxypropyl-β-cyclodextrin or β-cyclodextrin.
[0009] Preferably, the poloxamer is poloxamer 188.
[0010] The invention provides a method for preparing the inclusion compound, comprising the steps of mixing glycyrrhizin and poloxamer with ethanol, adding water for mixing, adding cyclodextrin and continuing to mix to obtain an inclusion compound solution; and drying the inclusion compound solution to obtain a glycyrrhizin cyclodextrin-poloxamer ternary supramolecular inclusion compound.
[0011] Preferably, when glycyrrhizin and poloxamer are mixed with ethanol, the amount of ethanol is 1 to 3 times the total weight of glycyrrhizin and poloxamer, the concentration of ethanol is 90 to 100%, the temperature during mixing is 40 to 60°C, and the time is 30 to 60 minutes.
[0012] Preferably, when adding water for mixing, the amount of water added is 6 to 10 times the total weight of the glycyrrhizin and poloxamer, the temperature during mixing is 40 to 60° C., and the time is 30 to 60 minutes.
[0013] Preferably, the temperature when adding cyclodextrin and continuing mixing is 40-60° C. and the time is 0.5-2 h.
[0014] Preferably, the drying is spray drying, and during spray drying, the air inlet temperature is 170-200°C, and the air outlet temperature is 70-90°C.
[0015] The present invention provides an application of the inclusion compound or the inclusion compound prepared according to the method in preparing a medicine for treating gastric ulcer.
[0016] Compared with the prior art, the present invention has the following beneficial effects:
[0017] Since glycyrrhizin is poorly soluble in water, it has extremely low solubility in human gastric juice, which makes the drug concentration formed in gastric juice extremely limited, greatly limiting the physiological activity and pharmacodynamics. The cyclodextrin inclusion method can effectively improve its water solubility, but the commonly used binary inclusion complexes, such as glycyrrhizin hydroxypropyl-β-cyclodextrin inclusion complex and glycyrrhizin β-cyclodextrin inclusion complex, can increase it by several to dozens of times, and its final solubility is still low, and the drug concentration reached in gastric juice is also very low. Due to the drug concentration, the drug efficacy is not maximized.
[0018] The inventors of the present invention surprisingly found that glycyrrhizin can form a ternary supramolecular inclusion complex with β-cyclodextrin or hydroxypropyl-β-cyclodextrin and poloxamer 188. Cyclodextrin has a hydrophilic cavity structure on the outside and a hydrophobic cavity on the inside. Glycyrrhizin and poloxamer 188 can be completely or partially embedded in the inner cavity of cyclodextrin to form a ternary supramolecular inclusion complex. The ternary supramolecular inclusion complex greatly increases the solubility and stability of glycyrrhizin in aqueous solution compared to the binary inclusion complex. Experiments have found that the ternary supramolecular inclusion complex formed after adding poloxamer 188 can significantly improve the solubility and bioavailability of glycyrrhizin, as well as the solubility and dissolution of glycyrrhizin in gastric juice. Compared with the glycyrrhizin raw material drug, the solubility is increased by more than 100 times. The DSC spectrum shows that the characteristic peaks of glycyrrhizin and poloxamer 188 in the DSC spectrum of the glycyrrhizin cyclodextrin poloxamer ternary supramolecular inclusion complex disappear, which is significantly different from the DSC spectrum of its physical mixture and each raw material component, indicating that a glycyrrhizin cyclodextrin poloxamer ternary supramolecular inclusion complex has been formed, which has its own unique new material structure and spectrum. The liquid chromatogram shows that the glycyrrhizin cyclodextrin poloxamer ternary supramolecular inclusion complex was washed twice with ethyl acetate, and there was no chromatographic peak in the ethyl acetate washing liquid after the second wash, while the liquid chromatographic fingerprint of the ternary supramolecular inclusion complex after washing had the same chromatographic peak as the glycyrrhizin raw material drug component, and the chemical composition of glycyrrhizin was not changed before and after the inclusion, indicating that a ternary supramolecular inclusion complex was formed.
[0019] The present invention has found that the ternary supramolecular inclusion compound prepared by the present invention has a significant repairing effect on the ulcer surface of rats with gastric ulcer modeled by the acetic acid method, which is significantly different from the licorice flavonoids raw material drug, and can effectively restore the original gastric mucosal wrinkle structure. The pharmacokinetic study found that the relative bioavailability of the ternary supramolecular inclusion compound prepared by the present invention in rabbits is 172.8% compared with the raw material drug, and the bioavailability is significantly improved.
[0020] The licorice flavonoids cyclodextrin poloxamer ternary supramolecular inclusion compound prepared by the present invention can also be added with appropriate auxiliary materials and prepared into various dosage forms such as tablets, granules, capsules, etc. according to conventional techniques. BRIEF DESCRIPTION OF THE DRAWINGS
[0021] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on the provided drawings without paying creative work.
[0022] Figure 1 is the DSC spectrum of licorice flavonoids in Experimental Example 1;
[0023] Figure 2 is the DSC spectrum of hydroxypropyl-β-cyclodextrin in Experimental Example 1;
[0024] Figure 3 is the DSC spectrum of β-cyclodextrin in Experimental Example 1;
[0025] Figure 4 is the DSC spectrum of Poloxamer 188 in Experimental Example 1;
[0026] Figure 5 The DSC spectrum of the physical mixture prepared in Comparative Example 1 in Experimental Example 1;
[0027] Figure 6 The DSC spectrum of the physical mixture prepared in Comparative Example 2 in Experimental Example 1;
[0028] Figure 7 is the DSC spectrum of the ternary supramolecular inclusion complex prepared in Example 1 of Experimental Example 1;
[0029] Figure 8 The DSC spectrum of the ternary supramolecular inclusion complex prepared in Example 2 of Experimental Example 1;
[0030] Fig. 9 Liquid chromatogram of the second washing solution of ethyl acetate in Test Example 2;
[0031] Fig.10 Liquid chromatogram of the ternary supramolecular inclusion complex after washing twice with ethyl acetate and then extracted with 80% ethanol in Experimental Example 2;
[0032] Fig.11 This is the liquid chromatogram of the licorice flavonoids raw material in Experimental Example 2. DETAILED DESCRIPTION
[0033] The technical solution provided by the present invention is described in detail below in conjunction with the examples, but they should not be construed as limiting the scope of protection of the present invention. The glycyrrhiza flavonoids used in the following examples are glycyrrhiza flavonoids extracts extracted from the residue after water extraction of glycyrrhiza uralensis.
[0034] Example 1
[0035] The preparation method of the ternary supramolecular inclusion complex of glycyrrhizin flavonoids cyclodextrin poloxamer comprises the following steps:
[0036] (1) 10 g of glycyrrhizin (the content of flavonoids in glycyrrhizin is 80%), 10 g of poloxamer 188 and 40 g of 95% ethanol were mixed and stirred at 60° C. for 60 min to dissolve glycyrrhizin and poloxamer 188, 160 g of water was added and mixed at 60° C. for 30 min, and then 40 g of hydroxypropyl-β-cyclodextrin was added and stirred at 60° C. for 1 h to obtain an inclusion compound solution;
[0037] (2) spray drying the inclusion complex solution obtained in step (1), wherein the air inlet temperature is 185° C. and the air outlet temperature is 80° C. during spray drying, to obtain a ternary supramolecular inclusion complex of glycyrrhizin cyclodextrin and poloxamer.
[0038] Example 2
[0039] The preparation method of the ternary supramolecular inclusion complex of glycyrrhizin flavonoids cyclodextrin poloxamer comprises the following steps:
[0040] (1) 11 g of glycyrrhizin (the content of flavonoids in glycyrrhizin is 85%), 15 g of poloxamer 188 and 26 g of 95% ethanol were mixed and stirred at 50° C. for 30 min to dissolve glycyrrhizin and poloxamer 188, and then 182 g of water was added and mixed at 50° C. for 60 min, and then 20 g of β-cyclodextrin was added and stirred at 50° C. for 1.5 h to obtain an inclusion compound solution;
[0041] (2) spray drying the inclusion complex solution obtained in step (1), wherein the air inlet temperature is 180° C. and the air outlet temperature is 85° C. during spray drying, to obtain a ternary supramolecular inclusion complex of glycyrrhizin cyclodextrin and poloxamer.
[0042] Example 3
[0043] The preparation method of the ternary supramolecular inclusion complex of glycyrrhizin flavonoids cyclodextrin poloxamer comprises the following steps:
[0044] (1) 4.5 g of glycyrrhizin (the content of flavonoids in glycyrrhizin is 90%), 10 g of poloxamer 188 and 43.5 g of 90% ethanol were mixed and stirred at 45° C. for 45 min to dissolve glycyrrhizin and poloxamer 188, and then 130.5 g of water was added and mixed at 45° C. for 30 min, and then 5 g of hydroxypropyl-β-cyclodextrin was added and stirred at 45° C. for 1 h to obtain an inclusion compound solution;
[0045] (2) spray drying the inclusion complex solution obtained in step (1), wherein the air inlet temperature is 190° C. and the air outlet temperature is 75° C. during spray drying, to obtain a ternary supramolecular inclusion complex of glycyrrhizin cyclodextrin and poloxamer.
[0046] Example 4
[0047] The preparation method of the ternary supramolecular inclusion complex of glycyrrhizin flavonoids cyclodextrin poloxamer comprises the following steps:
[0048] (1) 4 g of glycyrrhizin (the content of flavonoids in glycyrrhizin is 92%), 12.5 g of poloxamer 188 and 24.75 g of anhydrous ethanol were mixed and stirred at 40° C. for 30 min to dissolve glycyrrhizin and poloxamer 188, and then 165 g of water was added and mixed at 40° C. for 45 min, and then 15 g of hydroxypropyl-β-cyclodextrin was added and stirred at 40° C. for 0.5 h to obtain an inclusion compound solution;
[0049] (2) spray drying the inclusion complex solution obtained in step (1), wherein the air inlet temperature is 175° C. and the air outlet temperature is 70° C. during spray drying, to obtain a ternary supramolecular inclusion complex of glycyrrhizin cyclodextrin and poloxamer.
[0050] Example 5
[0051] The preparation method of the ternary supramolecular inclusion complex of glycyrrhizin flavonoids cyclodextrin poloxamer comprises the following steps:
[0052] (1) 6 g of glycyrrhizin (the content of flavonoids in glycyrrhizin is 88%), 15 g of poloxamer 188 and 52.5 g of 90% ethanol were mixed and stirred at 45° C. for 45 min to dissolve glycyrrhizin and poloxamer 188, and then 126 g of water was added and mixed at 45° C. for 60 min, and then 25 g of β-cyclodextrin was added and stirred at 45° C. for 1 h to obtain an inclusion compound solution;
[0053] (2) spray drying the inclusion complex solution obtained in step (1), wherein the air inlet temperature is 170° C. and the air outlet temperature is 90° C. during spray drying, to obtain a ternary supramolecular inclusion complex of glycyrrhizin cyclodextrin and poloxamer.
[0054] Example 6
[0055] The preparation method of the ternary supramolecular inclusion complex of glycyrrhizin flavonoids cyclodextrin poloxamer comprises the following steps:
[0056] (1) 5 g of glycyrrhizin (the content of flavonoids in glycyrrhizin is 86%), 5 g of poloxamer 188 and 30 g of 90% ethanol were mixed and stirred at 55° C. for 60 min to dissolve glycyrrhizin and poloxamer 188, and then 90 g of water was added and mixed at 55° C. for 45 min, and then 35 g of β-cyclodextrin was added and stirred at 55° C. for 2 h to obtain an inclusion compound solution;
[0057] (2) spray drying the inclusion complex solution obtained in step (1), wherein the air inlet temperature is 195° C. and the air outlet temperature is 70° C. during spray drying, to obtain a ternary supramolecular inclusion complex of glycyrrhizin cyclodextrin and poloxamer.
[0058] Example 7
[0059] The preparation method of the ternary supramolecular inclusion complex of glycyrrhizin flavonoids cyclodextrin poloxamer comprises the following steps:
[0060] (1) 4 g of glycyrrhizin (the content of flavonoids in glycyrrhizin is 95%), 7.5 g of poloxamer 188 and 23 g of anhydrous ethanol were mixed and stirred at 40° C. for 45 min to dissolve glycyrrhizin and poloxamer 188, and then 69 g of water was added and mixed at 40° C. for 30 min, and then 50 g of hydroxypropyl-β-cyclodextrin was added and stirred at 40° C. for 0.5 h to obtain an inclusion compound solution;
[0061] (2) spray drying the inclusion complex solution obtained in step (1), wherein the air inlet temperature is 200° C. and the air outlet temperature is 75° C. during spray drying, to obtain a ternary supramolecular inclusion complex of glycyrrhizin cyclodextrin and poloxamer.
[0062] Example 8
[0063] The preparation method of the ternary supramolecular inclusion complex of glycyrrhizin flavonoids cyclodextrin poloxamer comprises the following steps:
[0064] (1) 6 g of glycyrrhizin (the content of flavonoids in glycyrrhizin is 80%), 10 g of poloxamer 188 and 16 g of 95% ethanol were mixed and stirred at 60° C. for 30 min to dissolve glycyrrhizin and poloxamer 188, and then 112 g of water was added and mixed at 60° C. for 60 min, and then 40 g of hydroxypropyl-β-cyclodextrin was added and stirred at 60° C. for 1.5 h to obtain an inclusion compound solution;
[0065] (2) spray drying the inclusion complex solution obtained in step (1), wherein the air inlet temperature is 190° C. and the air outlet temperature is 80° C. during spray drying, to obtain a ternary supramolecular inclusion complex of glycyrrhizin cyclodextrin and poloxamer.
[0066] Example 9
[0067] The preparation method of the ternary supramolecular inclusion complex of glycyrrhizin flavonoids cyclodextrin poloxamer comprises the following steps:
[0068] (1) 4.5 g of glycyrrhizin (the content of flavonoids in glycyrrhizin is 85%), 15 g of poloxamer 188 and 58.5 g of 90% ethanol were mixed and stirred at 50° C. for 60 min to dissolve glycyrrhizin and poloxamer 188, and then 156 g of water was added and mixed at 50° C. for 45 min, and then 30 g of β-cyclodextrin was added and stirred at 50° C. for 2 h to obtain an inclusion compound solution;
[0069] (2) spray drying the inclusion complex solution obtained in step (1), wherein the air inlet temperature is 170° C. and the air outlet temperature is 85° C. during spray drying, to obtain a glycyrrhizin cyclodextrin poloxamer ternary supramolecular inclusion complex.
[0070] Example 10
[0071] The preparation method of the ternary supramolecular inclusion complex of glycyrrhizin flavonoids cyclodextrin poloxamer comprises the following steps:
[0072] (1) 5.5 g of glycyrrhizin (the content of flavonoids in glycyrrhizin is 87%), 12.5 g of poloxamer 188 and 18 g of anhydrous ethanol were mixed and stirred at 50° C. for 45 min to dissolve glycyrrhizin and poloxamer 188, and then 180 g of water was added and mixed at 50° C. for 30 min, and then 20 g of β-cyclodextrin was added and stirred at 50° C. for 1 h to obtain an inclusion compound solution;
[0073] (2) spray drying the inclusion complex solution obtained in step (1), wherein the air inlet temperature is 175° C. and the air outlet temperature is 90° C. during spray drying, to obtain a ternary supramolecular inclusion complex of glycyrrhizin cyclodextrin and poloxamer.
[0074] Embodiment 11
[0075] The preparation method of the ternary supramolecular inclusion complex of glycyrrhizin flavonoids cyclodextrin poloxamer comprises the following steps:
[0076] (1) 5 g of glycyrrhizin (the content of flavonoids in glycyrrhizin is 82%), 12.5 g of poloxamer 188 and 35 g of anhydrous ethanol were mixed and stirred at 40° C. for 30 min to dissolve glycyrrhizin and poloxamer 188, and then 140 g of water was added and mixed at 40° C. for 60 min, and then 25 g of hydroxypropyl-β-cyclodextrin was added and stirred at 45° C. for 1.5 h to obtain an inclusion compound solution;
[0077] (2) spray drying the inclusion complex solution obtained in step (1), wherein the air inlet temperature is 200° C. and the air outlet temperature is 85° C. during spray drying, to obtain a glycyrrhizin cyclodextrin poloxamer ternary supramolecular inclusion complex.
[0078] Example 12
[0079] The preparation method of the ternary supramolecular inclusion complex of glycyrrhizin flavonoids cyclodextrin poloxamer comprises the following steps:
[0080] (1) 5.5 g of glycyrrhizin (the content of flavonoids in glycyrrhizin is 90%), 7.5 g of poloxamer 188 and 19.5 g of 95% ethanol were mixed and stirred at 45° C. for 30 min to dissolve glycyrrhizin and poloxamer 188, and then 117 g of water was added and mixed at 45° C. for 45 min, and then 10 g of hydroxypropyl-β-cyclodextrin was added and stirred at 45° C. for 2 h to obtain an inclusion compound solution;
[0081] (2) spray drying the inclusion complex solution obtained in step (1), wherein the air inlet temperature is 180° C. and the air outlet temperature is 80° C. during spray drying, to obtain a ternary supramolecular inclusion complex of glycyrrhizin cyclodextrin and poloxamer.
[0082] Embodiment 13
[0083] The preparation method of the ternary supramolecular inclusion complex of glycyrrhizin flavonoids cyclodextrin poloxamer comprises the following steps:
[0084] (1) 6 g of glycyrrhizin (the content of flavonoids in glycyrrhizin is 85%), 10 g of poloxamer 188 and 40 g of 90% ethanol were mixed and stirred at 55° C. for 60 min to dissolve glycyrrhizin and poloxamer 188, and then 112 g of water was added and mixed at 55° C. for 30 min, and then 15 g of β-cyclodextrin was added and stirred at 55° C. for 0.5 h to obtain an inclusion compound solution;
[0085] (2) spray drying the inclusion complex solution obtained in step (1), wherein the air inlet temperature is 195° C. and the air outlet temperature is 90° C. during spray drying, to obtain a ternary supramolecular inclusion complex of glycyrrhizin cyclodextrin and poloxamer.
[0086] Embodiment 14
[0087] The preparation method of the ternary supramolecular inclusion complex of glycyrrhizin flavonoids cyclodextrin poloxamer comprises the following steps:
[0088] (1) 4 g of glycyrrhizin (the content of flavonoids in glycyrrhizin is 84%), 12.5 g of poloxamer 188 and 49.5 g of anhydrous ethanol were mixed and stirred at 60° C. for 45 min to dissolve glycyrrhizin and poloxamer 188, and then 132 g of water was added and mixed at 60° C. for 60 min, and then 45 g of β-cyclodextrin was added and stirred at 60° C. for 1.5 h to obtain an inclusion compound solution;
[0089] (2) spray drying the inclusion complex solution obtained in step (1), wherein the air inlet temperature is 170° C. and the air outlet temperature is 75° C. during spray drying, to obtain a ternary supramolecular inclusion complex of glycyrrhizin cyclodextrin and poloxamer.
[0090] Embodiment 15
[0091] The preparation method of the ternary supramolecular inclusion complex of glycyrrhizin flavonoids cyclodextrin poloxamer comprises the following steps:
[0092] (1) 4.5 g of glycyrrhizin (the content of flavonoids in glycyrrhizin is 82%), 15 g of poloxamer 188 and 29.25 g of 95% ethanol were mixed and stirred at 55° C. for 60 min to dissolve glycyrrhizin and poloxamer 188, and then 195 g of water was added and mixed at 55° C. for 30 min, and then 30 g of hydroxypropyl-β-cyclodextrin was added and stirred at 55° C. for 0.5 h to obtain an inclusion compound solution;
[0093] (2) spray drying the inclusion complex solution obtained in step (1), wherein the air inlet temperature is 185° C. and the air outlet temperature is 70° C. during spray drying, to obtain a ternary supramolecular inclusion complex of glycyrrhizin cyclodextrin and poloxamer.
[0094] Comparative Example 1
[0095] The preparation method of the physical mixture of glycyrrhizin, hydroxypropyl-β-cyclodextrin and poloxamer comprises the following steps:
[0096] 10 g of glycyrrhizin (the content of flavonoids in glycyrrhizin is 80%), 10 g of poloxamer 188 and 40 g of hydroxypropyl-β-cyclodextrin were mixed evenly to obtain a physical mixture of glycyrrhizin, hydroxypropyl-β-cyclodextrin and poloxamer.
[0097] Comparative Example 2
[0098] The preparation method of the physical mixture of glycyrrhizin, β-cyclodextrin and poloxamer comprises the following steps:
[0099] 11g of glycyrrhizin (the content of flavonoids in glycyrrhizin is 85%), 15g of poloxamer 188 and 20g of β-cyclodextrin were mixed evenly to obtain a physical mixture of glycyrrhizin, β-cyclodextrin and poloxamer.
[0100] Comparative Example 3
[0101] The preparation method of the glycyrrhiza flavonoids hydroxypropyl-β-cyclodextrin binary inclusion compound comprises the following steps:
[0102] 10 g of glycyrrhizin (the content of flavonoids in glycyrrhizin is 80%), 40 g of hydroxypropyl-β-cyclodextrin and 30 g of water were mixed and ground at room temperature for 1 h, dried and ground at 70° C. to obtain a glycyrrhizin hydroxypropyl-β-cyclodextrin binary inclusion complex.
[0103] Comparative Example 4
[0104] The preparation method of the licorice flavonoid β-cyclodextrin binary inclusion compound comprises the following steps:
[0105] 11 g of glycyrrhizin (the content of flavonoids in glycyrrhizin is 85%), 20 g of β-cyclodextrin and 30 g of water were mixed and ground at room temperature for 1 h, dried and ground at 70° C. to obtain a glycyrrhizin β-cyclodextrin binary inclusion complex.
[0106] Test Example 1 Thermal Analysis Measurement
[0107] 5 mg of glycyrrhizin (the content of flavonoids in glycyrrhizin is 80%), hydroxypropyl-β-cyclodextrin, β-cyclodextrin, poloxamer 188, the physical mixture prepared in Comparative Examples 1 and 2, and the ternary supramolecular inclusion complex prepared in Examples 1 and 2 (washed with ethyl acetate and dried) were taken respectively, and thermal analysis (DSC) was performed after tableting.
[0108] The DSC spectrum of licorice flavonoids is as follows Figure 1 As shown, the DSC spectrum of hydroxypropyl-β-cyclodextrin is as follows Figure 2 As shown, the DSC spectrum of β-cyclodextrin is as follows Figure 3 As shown, the DSC spectrum of Poloxamer 188 is as follows Figure 4 As shown, the DSC spectrum of the physical mixture prepared in Comparative Example 1 is as follows Figure 5 As shown, the DSC spectrum of the physical mixture prepared in Comparative Example 2 is as follows Figure 6 As shown, the DSC spectrum of the ternary supramolecular inclusion complex prepared in Example 1 is as follows Figure 7 As shown, the DSC spectrum of the ternary supramolecular inclusion complex prepared in Example 2 is as follows Figure 8 As shown. Figures 1 to 8 It can be seen that glycyrrhizin has characteristic endothermic peaks at 491.42℃ and 528.31℃, and poloxamer 188 has characteristic endothermic peaks at 54.22℃. The endothermic peaks of glycyrrhizin and poloxamer 188 disappear in the ternary supramolecular inclusion complex, while the endothermic peak of poloxamer 188 can be clearly seen in the physical mixture. It can be seen that the ternary supramolecular inclusion complex and the physical mixture present different endothermic states, indicating that the glycyrrhizin cyclodextrin poloxamer ternary supramolecular inclusion complex has been formed, which has a unique new material structure and spectrum.
[0109] Test Example 2 High Performance Liquid Chromatography Determination
[0110] 0.4 g of the ternary supramolecular inclusion complex prepared in Example 1 was placed in a conical flask, 20 mL of ethyl acetate solvent was added, shaken for 2 min, filtered, the filtrate was discarded, and the residue was washed with 20 mL of ethyl acetate solvent, shaken for 2 min, filtered, and the residue was reserved. The filtrate was collected, evaporated and dissolved in anhydrous ethanol, fixed to 25 mL, filtered, and the subsequent filtrate was taken as the test solution; at the same time, 0.2 g of the residue (ternary supramolecular inclusion complex) washed twice with ethyl acetate and dried was weighed, and 80% ethanol was added for 20 min of ultrasonic treatment and then fixed to 50 mL, filtered, and the subsequent filtrate was taken as the test solution; 0.1 g of glycyrrhizic flavonoids raw material (the content of flavonoids in glycyrrhizic flavonoids is 80%) was weighed, anhydrous ethanol was added for ultrasonic treatment, fixed to 50 mL, filtered, and injected. The liquid chromatography conditions are: C18 column, detection wavelength of 300nm, flow rate of 1.0mL / min, acetonitrile and 0.1% phosphoric acid solution as mobile phase, gradient of acetonitrile 19%→45% from 0 to 60min, acetonitrile 45%→62% from 60 to 80min, acetonitrile 62%→90% from 80 to 92min. The liquid chromatogram of the second ethyl acetate wash is shown in Fig. 9 As shown, the liquid chromatogram of the ternary supramolecular inclusion complex after secondary ethyl acetate washing and extraction with 80% ethanol is as follows Fig.10 As shown, the liquid chromatogram of the licorice flavonoids raw material is as follows Fig.11 shown.
[0111] Depend on Figures 9 to 11 It can be seen that the ternary inclusion complex prepared by the present invention is washed twice with ethyl acetate, and there is no chromatographic peak in the ethyl acetate washing solution after the second washing, while the liquid chromatography fingerprint of the ternary supramolecular inclusion complex after the second ethyl acetate washing is consistent with the fingerprint of the glycyrrhizin raw material drug component, indicating that the inclusion complex contains all the components of glycyrrhizin, and the chemical composition of glycyrrhizin is not changed before and after the inclusion, thus forming a ternary supramolecular inclusion complex.
[0112] Test Example 3 Encapsulation Efficiency and Solubility Determination
[0113] 1. Determination of encapsulation efficiency
[0114] 50 mg of the binary inclusion complex prepared in Comparative Examples 3 and 4 and the ternary supramolecular inclusion complex prepared by the method of Examples 1 to 15 were taken respectively, washed with ethyl acetate, the ethyl acetate was collected, evaporated and dissolved in anhydrous ethanol, fixed to 25 mL, filtered, and then 1 mL of the filtrate was accurately drawn, diluted to 10 mL with ethanol, and colorimetric determination was performed at a wavelength of 280 nm using a 1 cm colorimetric cell with liquiritin as a control to determine the total flavonoid content in the unencapsulated licorice flavonoids, and the encapsulation rate was calculated. The results are shown in Table 1. A blank test was performed in the same manner, and the blank sample had no absorption at a wavelength of 280 nm, indicating that the blank had no interference.
[0115] Encapsulation efficiency (%) = (1-unencapsulated drug amount / total drug amount of inclusion compound) × 100%
[0116] 2. Solubility determination
[0117] Weigh an excess of the binary inclusion complex prepared in Comparative Examples 3 and 4, the ternary supramolecular inclusion complex prepared in Examples 1 to 15, and the glycyrrhizin raw material drug (the content of flavonoids in glycyrrhizin is 80%) into a conical flask, add 50 mL of 0.1 mol / L hydrochloric acid solution to make it a supersaturated solution, place it in a 37°C constant temperature water bath and stir for 24 hours, take a sample, filter it, accurately draw 1 mL of the filtrate, dilute it to 10 mL with ethanol, use liquiritin as a control, use a 1 cm colorimetric cell at a wavelength of 280 nm to measure the absorbance, and calculate the solubility of total flavonoids in glycyrrhizin. The results are shown in Table 1. A blank test was performed in the same way, and the blank sample had no absorption at a wavelength of 280 nm, indicating that the blank had no interference.
[0118] Solubility (mg / mL) = total mass of dissolved flavonoids / volume of solvent
[0119] Table 1 Encapsulation efficiency and solubility test results of licorice flavonoids
[0120] Sample Project Licorice flavonoids encapsulation rate (%) Solubility (mg / mL) Example 1 87.9 25.0 Example 2 85.1 12.7 Example 3 83.2 18.5 Example 4 86.9 21.6 Example 5 84.7 10.4 Example 6 86.6 11.2 Example 7 85.8 23.4 Example 8 83.1 20.8 Example 9 84.2 9.5 Example 10 85.6 11.7 Embodiment 11 86.4 24.6 Example 12 84.9 18.7 Embodiment 13 87.1 8.9 Embodiment 14 86.2 11.5 Embodiment 15 85.7 22.1 Comparative Example 3 70.8 1.15 Comparative Example 4 68.3 0.32 Licorice flavonoids API — 0.05
[0121] It can be seen from Table 1 that, compared with Comparative Example 3 and Comparative Example 4, the encapsulation efficiency of the glycyrrhizin cyclodextrin poloxamer ternary supramolecular inclusion complexes of Examples 1 to 15 of the present invention is significantly improved; the solubility of glycyrrhizin in the ternary supramolecular inclusion complexes prepared in Examples 1 to 15 of the present invention is higher than that of the binary inclusion complexes prepared in Comparative Examples 3 and 4, while the solubility of the glycyrrhizin raw material in 0.1 mol / L hydrochloric acid solution is very low.
[0122] Test Example 4 Dissolution Test
[0123] Weigh appropriate amounts of the binary inclusion complex control samples prepared in Comparative Examples 3 and 4, the ternary supramolecular inclusion complex prepared in Examples 1 to 15 of the present invention, and the glycyrrhizin flavonoids raw material (the content of flavonoids in glycyrrhizin flavonoids is 80%), and use a ZRS-8G intelligent dissolution tester to measure the drug release at different times. The release medium is 250mL of 0.1mol / L hydrochloric acid solution, 100 rpm, temperature (37±0.5°C), 5mL is sampled at regular intervals, filtered, 1mL of the filtrate is accurately measured, diluted to 10mL with anhydrous ethanol, glycyrrhizin is used as a control, and colorimetric determination is performed at a wavelength of 280nm with a 1cm colorimetric cell. The results are shown in Table 2.
[0124] Table 2 The results of determination of the dissolution of flavonoids from licorice
[0125]
[0126] It can be seen from Table 2 that the solubility of the ternary supramolecular inclusion complex of glycyrrhizin prepared by the present invention is significantly higher than that of the binary inclusion complex and glycyrrhizin raw material drug prepared in Comparative Examples 3 and 4.
[0127] Test Example 5 Stability Test
[0128] The total flavonoid content and the solubility change at 15 min of the glycyrrhizin cyclodextrin poloxamer ternary supramolecular inclusion complex prepared in Examples 1 to 15 of the present invention were measured under the accelerated test conditions of temperature 37±1° C. and relative humidity 75%. The measurement results are shown in Table 3.
[0129] Table 3 Total flavonoids content and dissolution test results
[0130] time Taste Total flavonoid content (%) Dissolution (%) Month 0 good 97.9~101.5 93.4~95.9 Month 1 good 98.2~101.2 92.7~96.7 Month 2 good 98.1~100.7 93.5~96.3 Month 3 good 98.3~101.3 92.5~95.6
[0131] As shown in Table 3, with the extension of storage time, the total flavonoid content and solubility in the ternary supramolecular inclusion complex have no obvious changes, indicating that the ternary supramolecular inclusion complex prepared by the present invention has good stability.
[0132] Test Example 6 Anti-peptic ulcer test
[0133] Experimental groups: A total of 50 SD rats (provided by Liaoning Changsheng Biotechnology Co., Ltd.), half male and half female, were divided into 5 groups, 10 rats in each group, namely, ulcer model group, glycyrrhizin raw material drug (the content of flavonoids in glycyrrhizin is 80%) (GC) high and low dose groups, glycyrrhizin ternary supramolecular inclusion complex (NG) (Example 1) high and low dose groups.
[0134] Establishment of spleen deficiency type SD rat gastric ulcer model: After SD rats entered the laboratory, they were adaptively fed for 5 days. All animals were in good health and could be used for formal experiments. Rhubarb granules were used to prepare the spleen deficiency model of SD rats. Rhubarb granules were mixed with starch slurry at a ratio of 1:2 (w:w), and administered by gavage at a dose of 3mL / 200g, twice a day (9 am and 6 pm) for 9 consecutive days. During this period, fasting was performed during the day. After the spleen deficiency model was established, the rats fasted on the 10th day, and the rat gastric ulcer model was established using the modified acetic acid method. After intraperitoneal injection of 5% chloral hydrate 0.7mL / 100g for anesthesia, the rats were fixed on the operating table, the abdominal hair was cut below the xiphoid process, and the skin was prepared. The abdomen was opened about 1cm, and the stomach was separated and placed on sterile gauze moistened with saline. From the intersection of the lesser curvature of the stomach and the greater curvature of the stomach, the needle (50μL microsyringe) was inserted into the muscular layer for 2mm (based on the needle mark) and 5μL of glacial acetic acid was injected. From the midpoint of the greater curvature of the stomach to the lesser curvature of the stomach, the needle was inserted into the muscular layer for 2mm along the angle line and the muscular layer, and 5μL of glacial acetic acid was injected. The stomach was returned to the abdominal cavity with the handle of ophthalmic forceps, the greater omentum was pulled to cover the acetic acid injury site and the stomach was returned to the abdominal cavity, and then the abdominal wall was sutured with one stitch with a metabolizable suture, and then the cortex was sealed with a medical adhesive and transferred to a mouse cage with the abdomen facing up. After waking up from anesthesia, the mouse was allowed to eat freely, and a spleen deficiency type gastric ulcer model was obtained. The spleen deficiency type gastric ulcer model established was characterized by diarrhea, and the blood vessels around the ulcer showed inflammatory dilation.
[0135] Drug administration: On the third day after surgery, drug treatment was started, with doses of 0.15 g / kg and 0.30 g / kg (licorice flavonoids / kg animal), respectively. The control group was given an equal volume of solvent (1% gelatinized starch slurry), once a day for a total of 14 days. The gavage volume was 2 mL / 100 g rat.
[0136] Efficacy evaluation: After two weeks of administration, the ulcer area (S), bleeding rate and cure rate were used as efficacy evaluation indicators. Among them, the ulcer area was calculated using the area measurement software ImageJ. SPSS17.0 statistical software was used for data analysis, and the differences between the two groups were compared. P<0.05 was used to determine whether there was a significant difference. The results of the efficacy evaluation are shown in Table 4.
[0137] Table 4 Results of efficacy evaluation
[0138]
[0139] Among them, * indicates the comparison of ulcer area with the control group, and ** indicates the comparison of the same dose of glycyrrhizin and the ternary supramolecular inclusion complex.
[0140] As can be seen from Table 4, the ternary supramolecular inclusion compound prepared in Example 1 of the present invention has a significant repairing effect on rat ulcers modeled by the acetic acid method, which is significantly different from the glycyrrhizin raw material drug, indicating that the ternary supramolecular inclusion compound prepared in the present invention can effectively restore the wrinkled structure of rat gastric mucosa.
[0141] Test Example 7 Pharmacokinetic Test
[0142] 1. Animal grouping and treatment
[0143] Rabbits, 2.5-3.0 kg, male, provided by the Animal Experiment Center of Shenyang Medical College. Divided into 2 groups, the test group was intragastrically administered with the ternary supramolecular inclusion complex prepared in Example 1, and the control group was intragastrically administered with the licorice flavonoids raw material drug (the content of flavonoids in licorice flavonoids was 80%), the dosage was calculated as licorice flavonoids, 300 mg licorice flavonoids per rabbit, the main active ingredient was licochalcone A. Blood collection time: before and after administration at 0.25, 0.5, 1, 2, 3, 4, 5, 6, 7, 8 (h), blood was collected from the ear vein and placed in a heparinized centrifuge tube, and frozen for later use.
[0144] 2. Blood sample processing method
[0145] Take 1 mL of blood sample, add 1 mL of methanol, sonicate in ice water for 2 min, centrifuge for 5 min, take the supernatant for HPLC analysis, and determine the mass concentration of chalcone A.
[0146] 3. Liquid chromatography conditions
[0147] Chromatographic column: C18 column; mobile phase: methanol: water = 9:1 (v:v); detection wavelength: 372 nm; flow rate: 1 mL / mL.
[0148] 4. Standard curve
[0149] Blood sample collection: Weigh 3.6 mg of licorice chalcone A standard, make 50 mL of solution with mobile phase solution, and then dilute with mobile phase in equal times to obtain a series of concentrations of licorice chalcone A solution, and store in the refrigerator. Take a rabbit, collect blood from the ear vein and place it in a heparinized 2 mL centrifuge tube, 1 mL of blood in each tube, a total of twelve tubes. Add 0.1 mL of licorice chalcone A standard solution to each tube and shake it. After drying under reduced pressure at room temperature, add methanol, 1 mL per tube, and sonicate in ice water for 2 minutes. Balance and centrifuge for 5 minutes, take the supernatant for HPLC analysis, and determine the peak area and peak height of licorice chalcone A.
[0150] Standard curve drawing: With the peak area (Y) as the ordinate and the whole blood licorice chalcone A concentration (X) as the abscissa, linear regression was performed. The results showed that within the concentration range of 0.05 to 7.20 μg / mL, the linear relationship was good, and the regression equation was obtained: Y = 460.35X + 69.553 (R2 =0.9975).
[0151] 5. Blood drug concentration-time curve
[0152] After rabbits were orally administered the ternary supramolecular inclusion complex prepared in Example 1 and the glycyrrhizin flavonoids raw material drug, the blood drug concentration-time curve was plotted, and the blood drug concentration data were processed by DrugAnd Statistics 1.0 Chinese version pharmacokinetic software, and the pharmacokinetic parameters were calculated as shown in Table 5. Relative bioavailability calculation formula: RF (relative bioavailability) = (AUC1 / AUC2) × 100%
[0153] Table 5 Main pharmacokinetic parameters of licoricechalcone A after administration to rabbits
[0154] Group AUC (μg·h / mL) <![CDATA[t max (h)]]> Cmax(μg / mL) Experimental Group 9.26±0.71 1.0±0.1 4.1±0.24 Control group 5.36±0.47 1.0±0.0 2.56±0.17
[0155] It can be seen from Table 5 that, compared with the control group, the relative bioavailability of licoricechalcone A in the test group of rabbits after administration was 172.8%, indicating that the bioavailability of the ternary supramolecular inclusion complex prepared by the present invention was significantly improved.
[0156] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. Licorice flavonoids cyclodextrin poloxamer ternary supramolecular inclusion complex, characterized in that: The invention is prepared from the following components in parts by weight: 0.8-1.2 parts of glycyrrhizin flavonoids, 1-10 parts of cyclodextrin and 1-3 parts of poloxamer.
2. The inclusion compound according to claim 1, characterized in that The licorice flavonoids are licorice flavonoids extracts extracted from the residue after licorice is extracted with water, and the content of flavonoid compounds in the licorice flavonoids is ≥80.0%.
3. The inclusion compound according to claim 2, characterized in that The cyclodextrin is hydroxypropyl-β-cyclodextrin or β-cyclodextrin.
4. The inclusion compound according to claim 3, characterized in that The poloxamer is poloxamer 188.
5. A method for preparing the inclusion compound according to any one of claims 1 to 4, characterized in that: The glycyrrhizin and poloxamer are mixed with ethanol, and then water is added for mixing, and then cyclodextrin is added for further mixing to obtain an inclusion compound solution; the inclusion compound solution is dried to obtain a glycyrrhizin cyclodextrin poloxamer ternary supramolecular inclusion compound.
6. The method according to claim 5, characterized in that When the glycyrrhizin and poloxamer are mixed with ethanol, the amount of ethanol is 1 to 3 times the total weight of the glycyrrhizin and poloxamer, the concentration of the ethanol is 90 to 100%, the temperature during mixing is 40 to 60°C, and the time is 30 to 60 minutes.
7. The method according to claim 5, characterized in that When adding water for mixing, the amount of water added is 6 to 10 times the total weight of the glycyrrhizin and poloxamer, the temperature during mixing is 40 to 60° C., and the time is 30 to 60 minutes.
8. The method according to claim 5, characterized in that The temperature when adding cyclodextrin and continuing mixing is 40-60°C and the time is 0.5-2h.
9. The method according to any one of claims 5 to 8, characterized in that: The drying is spray drying, and during the spray drying, the air inlet temperature is 170-200°C, and the air outlet temperature is 70-90°C.
10. Use of the inclusion compound according to any one of claims 1 to 4 or the inclusion compound prepared by the method according to any one of claims 5 to 9 in the preparation of a drug for treating gastric ulcer.
Citation Information
Cited By
Preparation method for licoflavone multi-component supramolecular inclusion complex and gastric retention sustained-release formulation thereof and use thereof
WO2026040785A1
